A group of professionals collaborate around a laptop.

Expert-led, data-driven feasibility to de-risk trial design and execution

Trial design and site selection decisions are too costly to get wrong.

Sponsors today face escalating challenges:

  • 60% increase in protocol amendments since 20151

  • 7 months longer for trial timelines, 2020-242

  • $40K daily costs for Phase II and III trials3

  • $500K in lost sales daily3 from delays

''

Our Solution: Feasibility as a Service (FaaS)

FaaS is an expert-led, data-driven assessment that helps determine protocol viability, site selection strategies, recruitment plans, and mid-trial rescue decisions. Powered by Citeline's gold-standard Sitetrove and Trialtrove tools, our next-generation feasibility is now delivered as a service anchored in an independent and objective perspective to guide confident decisions.

With dynamic, decision-ready outputs, we help sponsors and their development partners de-risk design, adapt in real time, and keep studies on track without adding operational burden.

Related resources

A diverse group of people standing together in a casual setting.
SEP 24, 2025
Strategic Playbook
Clinical

From Protocol to Patient: A New Blueprint for Transforming Feasibility and Recruitment

This strategic playbook introduces a new, connected approach to feasibility, bridging the gap between protocol planning and patient delivery.

Collage showing hands typing on a laptop, a doctor using a tablet with AI and medical icons, and hands holding a tablet with healthcare symbols.
SEP 24, 2025
Webinar
Clinical

AI Won’t Replace You — But Clinical Teams Using It Might

Join experts as they reveal how AI is being used today across feasibility, site selection, and trial strategy — and why success depends on pairing AI with high-quality, expert-backed data.